Advances in Neoadjuvant Therapy for Locally Advanced Rectal Cancer
10.3971/j.issn.1000-8578.2022.21.0783
- VernacularTitle:局部进展期直肠癌新辅助治疗策略研究进展
- Author:
Yujuan JIANG
1
;
Sicheng ZHOU
;
Wei PEI
;
Jianwei LIANG
;
Zhixiang ZHOU
Author Information
1. Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
- Publication Type:Research Article
- Keywords:
Locally advanced rectal cancer;
Neoadjuvant therapy;
Watch & wait therapy;
Immunotherapy
- From:
Cancer Research on Prevention and Treatment
2022;49(3):235-239
- CountryChina
- Language:Chinese
-
Abstract:
The treatment of locally advanced rectal cancer (LARC) is extremely challenging, and it is difficult to achieve satisfactory results with surgical resection alone. In recent years, the diagnosis and treatment of LARC tends to be multi-disciplinary (MDT) mode. The emerging neoadjuvant treatment strategy is a milestone. At present, the preferred treatment for LARC is neoadjuvant chemoradiotherapy combined with total mesorectal excision. This article summarizes the main treatments of LARC neoadjuvant therapy, hoping to provide reference for clinical diagnosis and treatment.
